Risk prediction of hepatitis B virus-related hepatocellular carcinoma in the era of antiviral therapy

Table 4 Dynamic changes in risk scores and 5-year risk of hepatocellular carcinoma

Risk score		HCC in 5 yr
Baseline	2 yr	CU-HCC	GAG-HCC	REACH-B1
Low	Low	0.4%	1.4%	0.0%
Low	High	0.0%	NA	0.0%
High	Low	2.1%	5.1%	0.0%
High	High	12.9%	26.4%	2.1%

¹Only patients without cirrhosis were analyzed for the REACH-B score. Results adopted from Wong et al[22]. HCC: Hepatocellular carcinoma; NA: Not available.